TG THERAPEUTICS, INC. Cash Acquired from Acquisition
TG THERAPEUTICS, INC. (TGTX) reported Cash Acquired from Acquisition of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow
us-gaap:CashAcquiredFromAcquisition · last filed 2014-05-14
- TG THERAPEUTICS, INC. cash acquired from acquisition for the quarter ending 2014-03-31 was $0.00.
- TG THERAPEUTICS, INC. cash acquired from acquisition for the quarter ending 2013-12-31 was $0.00.
- TG THERAPEUTICS, INC. cash acquired from acquisition for the quarter ending 2013-09-30 was $0.00.
- TG THERAPEUTICS, INC. cash acquired from acquisition for the quarter ending 2013-06-30 was $0.00.
- TG THERAPEUTICS, INC. cash acquired from acquisition for fiscal 2013 was $0.00.
- TG THERAPEUTICS, INC. cash acquired from acquisition for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- TG THERAPEUTICS, INC. cash acquired from acquisition for fiscal 2011 was $10.39K.
| Period end | Cash Acquired from Acquisition 3 month | Cash Acquired from Acquisition 6 month | Cash Acquired from Acquisition 9 month | Cash Acquired from Acquisition 12 month | Cash Acquired from Acquisition 13 month | Cash Acquired from Acquisition 15 month | Cash Acquired from Acquisition 16 month | Cash Acquired from Acquisition 18 month | Cash Acquired from Acquisition 19 month | Cash Acquired from Acquisition 22 month | Cash Acquired from Acquisition 25 month | Cash Acquired from Acquisition 28 month | Cash Acquired from Acquisition 119 month | Cash Acquired from Acquisition 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $10.39K 10-Q · filed 2014-05-14 | |||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 | $10.39K 10-K · filed 2014-03-07 | |||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $10.39K 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $10.39K 10-Q · filed 2013-08-09 | |||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $10.39K 10-Q · filed 2013-05-14 | |||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 | $10.39K 10-K · filed 2013-03-21 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $10.39K derived: sum of 4 quarters · filed 2013-11-14 | $10.39K 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $10.39K derived: sum of 3 quarters · filed 2013-08-09 | $10.39K derived: sum of 4 quarters · filed 2013-08-09 | $10.39K 10-Q/A · filed 2012-09-07 | |||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | $10.39K derived: sum of 2 quarters · filed 2013-05-14 | $10.39K derived: sum of 3 quarters · filed 2013-05-14 | $10.39K 10-Q · filed 2012-05-14 | ||||||||||
| 2011-12-31 | $10.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $10.39K derived: sum of 2 quarters · filed 2013-03-21 | $10.39K 10-K · filed 2013-03-21 | |||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | $493.33K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | $493.33K 10-Q/A · filed 2011-09-14 | ||||||||||||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $519.37K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $519.37K 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |